NasdaqGS - Delayed Quote USD
Pliant Therapeutics, Inc. (PLRX)
1.6900
+0.0700
+(4.32%)
At close: May 2 at 4:00:00 PM EDT
1.7285
+0.04
+(2.28%)
After hours: May 2 at 7:47:25 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 365,825 | 6 |
| Sales | 134,221 | 6 |
| Net Shares Purchased (Sold) | 231,604 | 12 |
| Total Insider Shares Held | 1.86M | -- |
| % Net Shares Purchased (Sold) | 14.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEFEBVRE ERIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2025 |
| HULL JOHANNES P. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2025 |
| COULIE BERNARD J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2025 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2025 |
| OUIMETTE MICHAEL General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2025 |
| CHEUNG LILY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2025 |
| OUIMETTE MICHAEL General Counsel | Sale at price 10.99 - 11.20 per share. | Direct | 261,101 | Jan 22, 2025 |
| LEFEBVRE ERIC Officer | Sale at price 11.20 per share. | Direct | 206,974 | Jan 17, 2025 |
| HULL JOHANNES P. Officer | Sale at price 11.20 per share. | Direct | 178,501 | Jan 17, 2025 |
| COULIE BERNARD J Chief Executive Officer | Sale at price 11.20 per share. | Direct | 587,150 | Jan 17, 2025 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Sale at price 11.20 per share. | Direct | 225,680 | Jan 17, 2025 |
| CHEUNG LILY Officer | Sale at price 11.20 per share. | Direct | 41,892 | Jan 17, 2025 |
| LEFEBVRE ERIC Officer | Sale at price 11.56 per share. | Direct | 142,408 | Jul 10, 2024 |
| HULL JOHANNES P. Officer | Sale at price 11.56 per share. | Direct | 114,444 | Jul 10, 2024 |
| COULIE BERNARD J Chief Executive Officer | Sale at price 11.56 per share. | Direct | 447,488 | Jul 10, 2024 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Sale at price 11.56 per share. | Direct | 126,131 | Jul 10, 2024 |
| OUIMETTE MICHAEL General Counsel | Sale at price 11.56 per share. | Direct | 88,503 | Jul 10, 2024 |
| LEFEBVRE ERIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| HULL JOHANNES P. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| COULIE BERNARD J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| OUIMETTE MICHAEL General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 43,680 | May 2, 2024 |
| LEFEBVRE ERIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2024 |
| HULL JOHANNES P. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2024 |
| COULIE BERNARD J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2024 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2024 |
| OUIMETTE MICHAEL General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2024 |
| CHEUNG LILY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2024 |
| LEFEBVRE ERIC Officer | Sale at price 17.23 per share. | Direct | 177,383 | Jan 17, 2024 |
| HULL JOHANNES P. Officer | Sale at price 17.23 per share. | Direct | 168,613 | Jan 17, 2024 |
| COULIE BERNARD J Chief Executive Officer | Sale at price 17.23 per share. | Direct | 443,173 | Jan 17, 2024 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Sale at price 17.23 per share. | Direct | 168,527 | Jan 17, 2024 |
| OUIMETTE MICHAEL General Counsel | Sale at price 17.23 per share. | Direct | 89,544 | Jan 17, 2024 |
| HULL JOHANNES P. Officer | Sale at price 20.00 - 20.01 per share. | Direct | 698,580 | Aug 4, 2023 |
| HULL JOHANNES P. Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 22,029 | Aug 4, 2023 |
| OUIMETTE MICHAEL General Counsel | Sale at price 17.55 per share. | Direct | 83,450 | Jul 20, 2023 |
| LEFEBVRE ERIC Officer | Sale at price 18.01 per share. | Direct | 401,981 | Jul 17, 2023 |
| HULL JOHANNES P. Officer | Sale at price 18.01 per share. | Direct | 323,029 | Jul 17, 2023 |
| COULIE BERNARD J Chief Executive Officer | Sale at price 18.01 per share. | Direct | 1,263,338 | Jul 17, 2023 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Sale at price 18.01 per share. | Direct | 356,058 | Jul 17, 2023 |
| OUIMETTE MICHAEL General Counsel | Sale at price 18.01 per share. | Direct | 230,120 | Jul 17, 2023 |
| LEFEBVRE ERIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| HULL JOHANNES P. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| COULIE BERNARD J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| OUIMETTE MICHAEL General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 63,960 | Jun 13, 2023 |
| CUMMINGS KEITH LAMONT Chief Financial Officer | Conversion of Exercise of derivative security at price 2.08 per share. | Direct | 12,064 | Jun 9, 2023 |
Related Tickers
SPRB Spruce Biosciences, Inc.
0.0786
0.00%
ALEC Alector, Inc.
1.3000
+6.56%
ACRV Acrivon Therapeutics, Inc.
1.4100
+6.02%
KYTX Kyverna Therapeutics, Inc.
2.2800
+2.70%
LXEO Lexeo Therapeutics, Inc.
4.6400
-1.49%
MAZE Maze Therapeutics, Inc.
10.85
+2.46%
FDMT 4D Molecular Therapeutics, Inc.
3.7600
+9.30%
TNGX Tango Therapeutics, Inc.
1.5100
+7.09%
NKTX Nkarta, Inc.
2.0900
+1.95%
SEPN Septerna, Inc.
7.48
+4.76%